Mobile App

Google Play Apple Store
Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to Transform Patient Outcomes?
Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is associated with frequent bruising and bleeding. Current evidence suggests that low platelet counts in ITP are the result of multiple factors. Heterogeneity in patient population and characteristics make it challenging for the clinicians to choose appropriate therapeutic regimen. Clinicians must make decisions on the basis of the clinical presentation of each individual patient, ideally through a shared decision-making process that considers the patient’s values and preferences with respect to the anticipated outcomes of the chosen option.

In this webcast archive, Dr. James Bussel and Dr. Cindy Neunert discuss emerging evidence for management strategies for ITP, including utilization of patient reported outcomes and shared decision making to improve outcomes.
Review the activity to claim AMA/ABS/ANCC credit after completion of the brief Post-Test/Evaluations.

James Bussel, MD James Bussel, MD
Professor Emeritus
Pediatric Hematology-Oncology
Weill Cornell Medicine New York
New York, NY

Cindy Neunert, MD Cindy Neunert, MD
Division of Pediatric Hematology
Oncology, and Stem Cell Transplantation
Columbia University Irving Medical Center
New York, NY


Supported by an independent educational grant from Sobi, Inc.

Launch Date: December 8, 2023
Release Date: December 8, 2023
Expiration Date: November 30, 2024

November 30, 2024
Mini Module
TalkingITP_miniModules(1150x108) (1).png


Change Settings